1. Search Result

Search Result

Targets Recommended: CRISPR/Cas9

Results for "22252-07-9" in MCE Product Catalog:

Cat. No. Product Name Target Research Areas
  • HY-N9410
    Lysophosphatidylcholine 18:2


    Endogenous Metabolite Metabolic Disease
    Lysophosphatidylcholine 18:2 (1-Linoleoyl-2-Hydroxy-sn-glycero-3-PC), a lysophospholipid, is a potential biomarker identified from insulin resistance (IR) polycystic ovary syndrome (PCOS). Low plasma Lysophosphatidylcholine 18:2 also has been shown to predict impaired glucose tolerance, insulin resistance, type 2 diabetes, coronary artery disease, and memory impairment.